West Pharmaceutical Services, Inc. (WST)

West Pharmaceutical Services' stock experienced several notable events between October 2025 and April 2026. As of April 2, 2026, the stock price was $254.80, and on April 7, 2026, it was $259.35, showing a 1.36% increase over the past 30 days and a 15.03% increase over the past 12 months. In February 2026, the company reported strong fourth-quarter 2025 results, exceeding analyst estimates, and provided optimistic adjusted EPS guidance for 2026. In March 2026, West Pharmaceutical expanded its Damastown, Dublin facility.

While specific seasonality in demand is not explicitly stated, the demand for West Pharmaceutical Services' products and services is significantly influenced by trends in the pharmaceutical and biotechnology industries. The company has experienced robust demand for its high-value product components, particularly those tied to biologics and GLP-1 therapies, indicating a strong, consistent demand driven by ongoing medical advancements and market needs rather than traditional seasonal fluctuations.

West Pharmaceutical Services, Inc. is a U.S.-based healthcare company specializing in packaging components and delivery systems for injectable drugs and healthcare products. The company operates in the healthcare equipment & services sector, focusing on medical devices and pharmaceutical packaging and delivery systems. Its offerings include containment and delivery systems, proprietary products like vial containment solutions and self-injection systems, contract-manufactured products such as auto-injectors, and specific products like the SmartDose electronic wearable injector, along with analytical services.

Headquartered in Exton, Pennsylvania, West Pharmaceutical Services serves customers globally, with approximately 55% of its revenue from international markets and 45% from the United States. Key geographic regions include the U.S., Germany, Ireland, France, and other European Union countries. The company maintains 21 production sites worldwide, including facilities in the United States, Europe, Puerto Rico, and Brazil, as well as an office in Taipei, Asia.

West Pharmaceutical Services has maintained a positive brand reputation, marked by recognition for its responsible business practices. In February 2024, the company was named one of America's Climate Leaders by USA Today and listed as one of America's Most Responsible Companies by Newsweek, acknowledging its ESG business practices. The company also celebrated its 100th year in business in 2023.

West Pharmaceutical Services' ownership is predominantly institutional, with approximately 83.12% of the company's stock owned by institutional investors, 0.58% by insiders, and 16.30% by public companies and individual investors. Major institutional shareholders include The Vanguard Group, BlackRock, Inc., and State Street Corp.